
Rubius Therapeutics RUBY
Geschäftsbericht 2022
hinzugefügt 27.02.2023
Rubius Therapeutics P/CF 2011-2026 | RUBY
P/CF Jährlich Rubius Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0782 | -5.87 | -4.79 | -4.01 | -7.29 | -8.64 | -10.1 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.0782 | -10.1 | -5.83 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-1.79 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.848 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
-11.8 | - | -10.17 % | $ 12.2 K | ||
|
Adagene
ADAG
|
-14.3 | $ 3.94 | -1.5 % | $ 232 M | ||
|
Coherus BioSciences
CHRS
|
-1.63 | $ 1.65 | -0.6 % | $ 193 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Celldex Therapeutics
CLDX
|
-9.67 | $ 31.7 | 0.16 % | $ 2.11 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
48.3 | $ 93.44 | 0.47 % | $ 22.6 B | ||
|
AstraZeneca PLC
AZN
|
9.7 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-30.2 | - | 0.74 % | $ 768 M | ||
|
Compugen Ltd.
CGEN
|
6.2 | $ 2.78 | 0.72 % | $ 260 M | ||
|
Abcam plc
ABCM
|
172 | - | - | $ 4.9 B | ||
|
Galera Therapeutics
GRTX
|
-0.63 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-117 | - | -18.52 % | $ 27.3 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-4.21 | $ 0.76 | -2.25 % | $ 34.7 M | ||
|
Esperion Therapeutics
ESPR
|
-42.9 | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
53.1 | $ 31.86 | -1.67 % | $ 857 M | ||
|
Affimed N.V.
AFMD
|
-6.09 | - | -34.95 % | $ 21.5 M | ||
|
Forte Biosciences
FBRX
|
-6.59 | $ 20.77 | -3.26 % | $ 269 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | ||
|
Galectin Therapeutics
GALT
|
-7.47 | $ 2.57 | -4.81 % | $ 164 M | ||
|
Celyad Oncology SA
CYAD
|
-0.379 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
-3.39 | - | - | $ 344 M | ||
|
IMV
IMV
|
-0.195 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-2.88 | - | 0.23 % | $ 488 M | ||
|
Grifols, S.A.
GRFS
|
5.01 | $ 7.98 | -0.87 % | $ 5.42 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Hutchison China MediTech Limited
HCM
|
-186 | $ 11.23 | -4.18 % | $ 9.64 B | ||
|
Heron Therapeutics
HRTX
|
-7.19 | $ 0.89 | -1.97 % | $ 148 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 | - | -4.36 % | $ 27 M | ||
|
ImmuCell Corporation
ICCC
|
23.4 | $ 9.9 | -6.87 % | $ 89.4 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-3.33 | - | - | $ 384 M | ||
|
Gracell Biotechnologies
GRCL
|
-6.52 | - | - | $ 3.37 B | ||
|
Anika Therapeutics
ANIK
|
19.1 | $ 14.9 | 0.61 % | $ 214 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-1.01 | - | 5.93 % | $ 314 M | ||
|
CRISPR Therapeutics AG
CRSP
|
-12.7 | $ 56.38 | 5.32 % | $ 5.07 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.205 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M |